Likewise, in our in vivo model, the finding suggested that if the in vivo levels of SPARC are low, the expression of MMP-2/9 and p-ERK would be downregulated to suppress the formation and development of ectopic HCC cell tumor, thereby inhibiting the proliferation of the tumor (Figure 3). This evidence concerns the gene MMP2 and hepatocellular carcinoma.